Search result for 'takeda'

Alkem Licenses Takeda's Vonoprazan for India

September 2, 2024 18:08

Alkem Laboratories has signed a licensing agreement with Takeda to commercialize Vonoprazan, a drug for reflux esophagitis and other gastrointestinal conditions, in India.

Dr Reddy's Licenses Takeda's Gastrointestinal Drug Vonoprazan

July 18, 2024 18:49

Dr Reddy's Laboratories has inked a licensing deal with Takeda Pharmaceutical to commercialize Vonoprazan tablets in India, a novel treatment for reflux esophagitis and other acid peptic disorders.

Zydus Licenses Takeda's GERD Drug Vonoprazan for India

July 17, 2024 17:59

Zydus Lifesciences has signed a licensing deal with Takeda to market Vonoprazan, a P-CAB drug for GERD, in India under the brand name Vault.

Sun Pharma & Takeda Partner for Gastrointestinal Drug in India

June 21, 2024 10:05

Sun Pharma has partnered with Takeda to bring Vonoprazan, a novel gastrointestinal drug, to the Indian market. This partnership aims to provide patients with a new treatment option for reflux...

Alembic Pharma Gets USFDA Approval for Hereditary Angioedema Injection

June 17, 2024 13:29

Alembic Pharmaceuticals receives USFDA approval for its generic Icatibant injection, a treatment for acute attacks of hereditary angioedema (HAE) in adults. This is the company's first peptide...

Torrent Pharma Licenses Vonoprazan GERD Drug from Takeda

June 5, 2024 16:45

Torrent Pharmaceuticals has licensed Vonoprazan, a novel P-CAB for GERD treatment, from Takeda. The drug will be marketed in India under the brand name Kabvie.

India's Growing Appeal for Clinical Trials: Pharma Leaders Speak

April 27, 2024 19:35

Pharma industry leaders highlight India's rising attractiveness for clinical trials, citing recent reforms and a robust healthcare infrastructure. Learn about the factors driving this trend.

Takeda & Biological E Partner to Manufacture Dengue Vaccine

February 27, 2024 13:02

Japanese drug firm Takeda and Hyderabad-based Biological E team up to manufacture a dengue vaccine, aiming to increase global access and fight the disease.

Takeda & Biological E Partner for Dengue Vaccine Access

February 27, 2024 12:46

Takeda and Biological E. Limited announce a partnership to increase production of Qdenga (Dengue Tetravalent Vaccine) to expand access in endemic countries by 2030.

Lupin Gets USFDA Approval for Generic Hyperuricemia Drug

January 18, 2024 17:37

Lupin receives USFDA approval to market generic Febuxostat tablets for the treatment of hyperuricemia in adults with gout. The drug, a generic equivalent of Uloric, will be manufactured in India.

Web Werks to Build Rs 20,000 Crore Data Centre in Bengaluru

January 17, 2024 16:22

Web Werks India will invest Rs 20,000 crore to build a data centre park in Bengaluru, Karnataka. The MoU was signed at the World Economic Forum in Davos.

Karnataka Signs Rs 22,000 Crore MoUs at Davos WEF

January 17, 2024 12:59

Karnataka government signs MoUs worth Rs 22,000 crore with 7 companies at Davos WEF, including a Rs 20,000 crore data centre park by Web Werks.

Company Name
Price
Volume

Bajaj Housing Fin
178.26 ( -1.77)
11312440

Gennex Laboratories
27.81 (+ 4.35)
8102505

Vodafone Idea L
13.07 ( -0.38)
6628604

Spicejet Ltd.
72.50 ( -1.65)
6429364

ARC Finance
2.31 (+ 5.00)
6419660

Indian Markets Decline: IT Stocks Drag | US Fed...

Indian stock markets opened lower on Wednesday, led by IT stocks, as investors await...

Amazon Appoints Samir Kumar as India Country...

Amazon has announced that Samir Kumar will take over as the new Country Manager for...

IGREL Renewables Raises Rs 300 Crore for...

INOXGFL Group's renewable energy platform, IGREL Renewables, has raised Rs 300 crore...

Moneywiz Live!

ALL MONEYWIZ PAGES

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us